IRIS Accounts Production v25.4.0.155 02352745 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh023527452024-03-31023527452025-03-31023527452024-04-012025-03-31023527452023-03-31023527452023-04-012024-03-31023527452024-03-3102352745ns15:EnglandWales2024-04-012025-03-3102352745ns14:PoundSterling2024-04-012025-03-3102352745ns10:Director12024-04-012025-03-3102352745ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3102352745ns10:SmallEntities2024-04-012025-03-3102352745ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3102352745ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3102352745ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3102352745ns10:FullAccounts2024-04-012025-03-310235274512024-04-012025-03-3102352745ns10:Director22024-04-012025-03-3102352745ns10:RegisteredOffice2024-04-012025-03-3102352745ns5:CurrentFinancialInstruments2025-03-3102352745ns5:CurrentFinancialInstruments2024-03-3102352745ns5:ShareCapital2025-03-3102352745ns5:ShareCapital2024-03-3102352745ns5:RetainedEarningsAccumulatedLosses2025-03-3102352745ns5:RetainedEarningsAccumulatedLosses2024-03-3102352745ns5:NetGoodwill2024-04-012025-03-3102352745ns5:ComputerSoftware2024-04-012025-03-3102352745ns5:PlantMachinery2024-04-012025-03-3102352745ns5:NetGoodwill2024-03-3102352745ns5:IntangibleAssetsOtherThanGoodwill2024-03-3102352745ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3102352745ns5:NetGoodwill2025-03-3102352745ns5:IntangibleAssetsOtherThanGoodwill2025-03-3102352745ns5:NetGoodwill2024-03-3102352745ns5:IntangibleAssetsOtherThanGoodwill2024-03-3102352745ns5:FurnitureFittings2024-03-3102352745ns5:ComputerEquipment2024-03-3102352745ns5:FurnitureFittings2024-04-012025-03-3102352745ns5:ComputerEquipment2024-04-012025-03-3102352745ns5:FurnitureFittings2025-03-3102352745ns5:ComputerEquipment2025-03-3102352745ns5:FurnitureFittings2024-03-3102352745ns5:ComputerEquipment2024-03-3102352745ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3102352745ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3102352745ns5:WithinOneYear2025-03-3102352745ns5:WithinOneYear2024-03-310235274512024-04-012025-03-31
REGISTERED NUMBER: 02352745 (England and Wales)















DOCTORCALL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025






DOCTORCALL LIMITED (REGISTERED NUMBER: 02352745)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3 to 6


DOCTORCALL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Dr C M Levinson
S Vireswer





REGISTERED OFFICE: 121 Harley Street
London
W1G 6AX





REGISTERED NUMBER: 02352745 (England and Wales)





ACCOUNTANTS: Duncan & Toplis Limited
3 Castlegate
Grantham
Lincolnshire
NG31 6SF

DOCTORCALL LIMITED (REGISTERED NUMBER: 02352745)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 83,608 29,839
Tangible assets 5 23,993 50,054
107,601 79,893

CURRENT ASSETS
Debtors 6 898,403 2,028,698
Cash at bank and in hand 534,030 423,681
1,432,433 2,452,379
CREDITORS
Amounts falling due within one year 7 572,333 434,798
NET CURRENT ASSETS 860,100 2,017,581
TOTAL ASSETS LESS CURRENT LIABILITIES 967,701 2,097,474

PROVISIONS FOR LIABILITIES 26,443 18,046
NET ASSETS 941,258 2,079,428

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 941,158 2,079,328
SHAREHOLDERS' FUNDS 941,258 2,079,428

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 December 2025 and were signed on its behalf by:





S Vireswer - Director


DOCTORCALL LIMITED (REGISTERED NUMBER: 02352745)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Doctorcall Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Revenue
Turnover represents amounts receivable for goods and services provided.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 1 year.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of three and ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost and Straight line over 3 years

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

DOCTORCALL LIMITED (REGISTERED NUMBER: 02352745)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has chosen to adopt the FRS 102A in respect of financial instruments.

Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at transaction price, unless the arrangement constitute a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in the income statement.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 23 (2024 - 26 ) .

DOCTORCALL LIMITED (REGISTERED NUMBER: 02352745)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
At 1 April 2024 3 44,755 44,758
Additions - 76,380 76,380
At 31 March 2025 3 121,135 121,138
AMORTISATION
At 1 April 2024 3 14,916 14,919
Charge for year - 22,611 22,611
At 31 March 2025 3 37,527 37,530
NET BOOK VALUE
At 31 March 2025 - 83,608 83,608
At 31 March 2024 - 29,839 29,839

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2024 7,390 321,285 328,675
Additions 1,956 1,117 3,073
Disposals - (7,382 ) (7,382 )
At 31 March 2025 9,346 315,020 324,366
DEPRECIATION
At 1 April 2024 1,551 277,070 278,621
Charge for year 2,811 26,323 29,134
Eliminated on disposal - (7,382 ) (7,382 )
At 31 March 2025 4,362 296,011 300,373
NET BOOK VALUE
At 31 March 2025 4,984 19,009 23,993
At 31 March 2024 5,839 44,215 50,054

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 226,934 224,315
Amounts owed by group undertakings 645,020 1,777,174
Other debtors 26,449 27,209
898,403 2,028,698

DOCTORCALL LIMITED (REGISTERED NUMBER: 02352745)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 145,768 175,098
Amounts owed to group undertakings 65,262 65,262
Taxation and social security 173,933 96,566
Other creditors 187,370 97,872
572,333 434,798

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
£    £   
Within one year - 15,923

9. CALLED UP SHARE CAPITAL

Allotted, issued and full paid:

Number: Class: Nominal 2025 2024
£ £

450 A Ordinary £0.1 45 45
550 B Ordinary £0.1 55 55
100 100

10. POST BALANCE SHEET EVENTS

A dividend of £1,777,173 was declared on 24 September 2024. These financial statements do not reflect the dividends payable which will be accounted for in shareholder's equity as an appropriation of retained earnings in the year ended 31 March 2025.